quinoxalines has been researched along with Ameloblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauman, JE; Lawson-Michod, KA; Le, CH; Thomas, PC; Tranesh, G | 1 |
1 other study(ies) available for quinoxalines and Ameloblastoma
| Article | Year |
|---|---|
Precision medicine: Sustained response to erdafitinib in FGFR2-mutant, multiply recurrent ameloblastoma.
Topics: Adult; Ameloblastoma; B7-H1 Antigen; Humans; Male; Precision Medicine; Pyrazoles; Quality of Life; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 2 | 2022 |